Cargando…
Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis
The objective of this study was to investigate the interaction between levels of BAFF (B-cell activation factor of the tumour necrosis factor [TNF] family) and APRIL (a proliferation-inducing ligand) and B-cell frequencies in patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis...
Autores principales: | Vallerskog, Therese, Heimbürger, Mikael, Gunnarsson, Iva, Zhou, Wei, Wahren-Herlenius, Marie, Trollmo, Christina, Malmström, Vivianne |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1794511/ https://www.ncbi.nlm.nih.gov/pubmed/17092341 http://dx.doi.org/10.1186/ar2076 |
Ejemplares similares
-
Rituximab in Systemic Lupus Erythematosus: Transient Effects on Autoimmunity Associated Lymphocyte Phenotypes and Implications for Immunogenicity
por: Faustini, Francesca, et al.
Publicado: (2022) -
Modulating co-stimulation: a rational strategy in the treatment of rheumatoid arthritis?
por: Malmström, Vivianne, et al.
Publicado: (2005) -
First exposure to rituximab is associated to high rate of anti-drug antibodies in systemic lupus erythematosus but not in ANCA-associated vasculitis
por: Faustini, Francesca, et al.
Publicado: (2021) -
Raised intrathecal levels of APRIL and BAFF in patients with systemic lupus erythematosus: relationship to neuropsychiatric symptoms
por: George-Chandy, Annie, et al.
Publicado: (2008) -
Protein and functional isoform levels and genetic variants of the BAFF and APRIL pathway components in systemic lupus erythematosus
por: Ortiz-Aljaro, Pilar, et al.
Publicado: (2022)